Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The role of nanotechnology in creating novel antitumor agents].
Semiglazov VF, Paltuev RM, Remizov AS, Semiglazov VV, Dashian GA, Bessonov AA, Pen'kov KD, Vasil'ev AG, Semiglazova TIu, Kolar'kova VV. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2011;57(5):636-40. Vopr Onkol. 2011. PMID: 22238935 Russian.
[New results of endocrine therapy of breast cancer (the role of Aromasin)].
Semiglazov VF, Semiglazov VV, Klemtsel' AA, Barash NIu, Zhil'tsova EK, Bozhok AA, Mel'nikova OA, Paltuev RM, Dashian GA, Petrovskiĭ SG, Ivanov VG, Tonuzov EE, Berstein LM. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2004;50(6):729-36. Vopr Onkol. 2004. PMID: 15755074 Russian. No abstract available.
[Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer].
Semiglazov VF, Semiglazov VV, Dashian GA, Zhil'tsova EK, Ivanov VG, Bozhok AA, Tonuzov EE, Paltuev RM, Mel'nikova OA, Klettsel' AA, Krivorot'ko PV, Donskikh RV, Kochetova IA, Damenia AO, Zernov KIu, Voskresenskiĭ DA, Bershteĭn LM. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2007;53(4):400-8. Vopr Onkol. 2007. PMID: 17969401 Clinical Trial. Russian.
[HER2-positive breast cancer: standard and double targeted therapy].
Semiglazov VF, Bozhok AA, Semiglazova TIu, Vasil'ev AG, Manikhas AG, Semiglazov VV, Bessonov AA, Nikolaev KS. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2013;59(3):341-6. Vopr Onkol. 2013. PMID: 23909035 Clinical Trial. Russian.
[BREAST-CONSERVING SURGERY AFTER NEOADJUVANT THERAPY FOR BREAST CANCER].
Semiglazov VF, Semiglazov VV, Petrenko OL, Komyakhov AV, Dashyan GA, Paltuev RM, Semiglazova TY, Manikhas AG, Bozhok AA, Lalak IA. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2015;61(3):381-6. Vopr Onkol. 2015. PMID: 26242149 Clinical Trial. Russian.
[Taxotere application in the management of breast cancer].
Bozhok AA, Semiglazov VF, Kletcel' AE, Arzumanov AS, Ivanova OA, Semiglazov VV. Bozhok AA, et al. Among authors: semiglazov vf, semiglazov vv. Vopr Onkol. 2005;51(2):253-60. Vopr Onkol. 2005. PMID: 16223013 Review. Russian. No abstract available.
248 results